Cyclo Therapeutics Inc (CYTH)
0.7216
-0.03
(-3.53%)
USD |
NASDAQ |
Nov 01, 16:00
0.7228
0.00 (0.00%)
After-Hours: 20:00
Cyclo Therapeutics Shareholders Equity (Quarterly): -5.123M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -5.123M |
March 31, 2024 | 0.61M |
December 31, 2023 | 4.757M |
September 30, 2023 | -1.053M |
June 30, 2023 | -1.485M |
March 31, 2023 | -0.4389M |
December 31, 2022 | 0.7345M |
September 30, 2022 | 5.612M |
June 30, 2022 | 9.74M |
March 31, 2022 | 13.05M |
December 31, 2021 | 15.67M |
September 30, 2021 | 7.627M |
June 30, 2021 | 11.13M |
March 31, 2021 | 14.32M |
December 31, 2020 | 10.45M |
September 30, 2020 | -0.5245M |
June 30, 2020 | -1.92M |
March 31, 2020 | -1.698M |
December 31, 2019 | 0.936M |
September 30, 2019 | 3.483M |
June 30, 2019 | 4.84M |
March 31, 2019 | -0.7816M |
December 31, 2018 | 0.9925M |
September 30, 2018 | 0.2161M |
June 30, 2018 | 1.003M |
Date | Value |
---|---|
March 31, 2018 | 0.3327M |
December 31, 2017 | 1.146M |
September 30, 2017 | 1.040M |
June 30, 2017 | 1.629M |
March 31, 2017 | 2.457M |
December 31, 2016 | 1.526M |
September 30, 2016 | 2.358M |
June 30, 2016 | 3.849M |
March 31, 2016 | 3.040M |
December 31, 2015 | 3.746M |
September 30, 2015 | 4.801M |
June 30, 2015 | 3.638M |
March 31, 2015 | 3.998M |
December 31, 2014 | 4.370M |
September 30, 2014 | 4.610M |
June 30, 2014 | 3.143M |
March 31, 2014 | 2.354M |
December 31, 2013 | 1.795M |
September 30, 2013 | 1.879M |
June 30, 2013 | 1.932M |
March 31, 2013 | 1.669M |
December 31, 2012 | 1.549M |
September 30, 2012 | 1.418M |
June 30, 2012 | 1.414M |
March 31, 2012 | 1.470M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.123M
Minimum
Jun 2024
15.67M
Maximum
Dec 2021
4.337M
Average
0.936M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Stryker Corp | 20.15B |
Biogen Inc | 16.36B |
Pfizer Inc | 87.70B |
Pacira BioSciences Inc | 879.28M |
Moderna Inc | 11.71B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.718M |
Total Liabilities (Quarterly) | 9.841M |
Debt to Equity Ratio | -0.5292 |
Current Ratio | 0.4528 |
Net Debt Paydown Yield | -1.49% |